Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
group of 3 individuals working at office table with laptop computers

Pay equity

Our goal for pay equity: We aim to achieve pay equity across our global operations.

When it comes to equity, we start by looking at ourselves.

Since our company’s launch, we have completed two waves of studies examining gender (globally) and race/ethnicity (U.S. only) pay equity, representing nearly 50% of our employees.

diverse group of people in various professions climbing large blocks and supporting each other

We’re excited about our progress and our top-tier results – and we know we have more to do.

In 2024, we will capture more countries as we continue our commitment to achieve pay equity across our global operations.

We’re proud that we have achieved 100% balance in pay equity among the approximately 50% of our employees studied in countries across North America, South America, Europe and Asia/Pacific.

globe earth icon

In 2023, we engaged external economic and legal experts and expanded from our first pay equity study to cover a notably larger number of employes than the 2022 study.

balanced scale icon

The 2023 study showed that we have achieved 100% balance in pay equity for similarly situated female and male employees in equivalent positions.1

employees icon

Additionally, the 2023 pay equity study for the United States showed that we have achieved 100% balance in pay equity for similarly situated non-White (including Black, Hispanic, and Asian employees) and White employees in equivalent positions.1,2

These studies were conducted as a follow up to the studies conducted in 2022 — a commitment that was declared in our 2022 ESG Report.

Continuing this commitment

Going forward, we intend to continue to use comprehensive evaluative approaches to support equitable decision-making regarding compensation allocation within our organization. These include regular pay equity studies in more countries during the next two years and the continuation of our Performance and Rewards @ Organon program, which is designed to help foster pay equity practices.

Progress

pay equity results chart

1 Adjusted to account for legitimate labor economic factors.

2 Due to local legal and regulatory requirements, there was insufficient information available to conduct this second analysis outside the United States.

3 Underrepresented ethnic groups are defined as: Asian, Black, Latino/Hispanic, and other ethnic groups (e.g., American Indian, Alaska Native, Native Hawaiian, or other Pacific Islander).

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept